Antihypertensive and renal effects of acute and chronic therapy with a dihydropyridine Ca-antagonist in patients with different salt sensitivity

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 4, 1996, Pages 578-582

  Galletti, Ferruccio ^a,b   Strazzullo, P ^a   Barba, G ^a   Ferrara, I ^a   Iacone, R ^a   Stinga, F ^a   Mancini, M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Ca antagonist; Calcium; Hypertension; Nitrendipine; Salt sensitivity; Sodium; Urinary Na and Ca excretion

Indexed keywords

CALCIUM; CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; NITRENDIPINE; SODIUM; SODIUM CHLORIDE;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CALCIUM EXCRETION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; HUMAN; HYPERTENSION; MALE; NATRIURESIS; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SALT LOADING;

ADULT; BLOOD PRESSURE; CALCIUM; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITRENDIPINE; SODIUM; SODIUM CHLORIDE;

EID: 0029967668     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199604000-00018     Document Type: Article

References (38)

1. Aoki K, Kando S, Mochizuchi A. Antihypertensive effects of cardiovascular calcium-antagonists in hypertensive patients in the absence of beta-adrenergic blockade. Am Heart J 1978;96:218-26.
2. Buhler FR, Hulthen UL, Bolli P. Calcium channel inhibitors for identification of mechanisms and treatment of hypertension. J Cardiovasc Pharmacol 1982;4:S267-8.
3. Andren L, Hansson L, Oro L, Ryman T. Experience with nitrendipine, a new calcium antagonist in hypertension. J Cardiovasc Pharmacol 1982;4:8387-91.
4. Ferrara LA, Fasano ML, de Simone G, Soro S, Gagliardi R. Antihypertension and cardiovascular effects of nitrendipine: a controlled study vs. placebo. Clin Pharmacol Ther 1985; 38:435-8.
5. Galletti F, Strazzullo P, Cappuccio FP, et al. Calcium-channel blockers and sodium intake: a controlled study in patients with essential hypertension. Cardiovasc Drugs Ther 1989;3:135-40.
6. Galletti F, Rutledge A, Triggle DJ. Dietary sodium intake: influence on calcium channels and urinary calcium excretion in spontaneously hypertensive rats. Biochem Pharmacol 1991;41:893-6.
7. MacGregor GA, Pevahouse JB, Cappuccio FP, Markandu ND. Nifedipine, sodium intake, diuretics and sodium balance. Am J Nephrol 1987;7(suppl 7):44-8.
8. Leonetti G, Rupoli L, Gradnik R, Zanchetti A. Effects of a low-sodium diet on antihypertensive and natriuretic responses to acute administration of nifedipine. J Hypertens 1987;5(suppl 4):S57-60.
9. Leenen FHH. Yuan B. Dietary sodium and the antihypertensive effect of nifedipine in spontaneously hypertensive rats. Am J Hypertens 1992;5:515-9.
10. Grim CE, Luft FC, Fineberg NS, Weinberger MH. Response to volume expansion and contraction in categorized hypertensive and normotensive men. Hypertension 1979;1: 476-85.
11. SPSS Inc. SPSSX user's guide. New York: McGraw-Hill. 1983.
12. Muntzel M, Druke T. A comprehensive review of the salt and blood pressure relationship. Am J Hypertens 1992;5:1S-42S.
13. Weinberger MH, Stegner JE, Fineberg NS. A comparison of two tests for the assessment of blood pressure response to sodium. Am J Hypertens 1993;6:179-84.
14. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure. Hypertension 1991;18:67-71.
15. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? I. Analysis of observational data among populations. Br Med J 1991;302:811-5.
16. Miller JZ, Weinberger MH, Dougherty SA, et al. Heterogeneity of blood pressure responses to dietary sodium restriction in normotensive adults. J Chronic Dis 1987;40:245-50.
17. Myers J, Morgan T. The effect of sodium intake on the blood pressure related to age and sex. Clin Exp Hypertens [A] 1983;A5:99-1I8.
18. Koolen MI, Bussemaker-Verduyn der Boer E. Clinical, biochemical, and hemodynamic correlates of sodium sensitivity in essential hypertension. J Hypertens 1983;1(suppl 2):21-3.
19. Morgan T, Nowson C. The role of sodium restriction in the management of hypertension. Can J Physiol Pharmacol 1986,49:1132-46.
20. Weinberger MH, Miller JZ, Luft FC. et al. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986;8(suppl II):II127-34.
21. Fujita T, Henry WL, Bartter FC, et al. Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med 1980;69:334-44.
22. Morgan T, Creed R, Hopper J. Factors that determine the response of people with mild hypertension to a reduced sodium intake. Clin Exp Hypertens [A] 1986;A8:941-62.
23. Campese VM, Parise M, Karubian F, Bigazzi R. Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension 1991;18:805-12.
24. Weinberger MH, Wagner UL, Fineberg SF. Salt sensitivity and the blood pressure response to verapamil. Am J Hypertens 1994;7:515-9.
25. Resnick LM, Nicholson JP, Laragh JH. The effects of calcium blockade on blood pressure and calcium metabolism. Am J Hypertens 1989;2:927-30.
26. Krusell LR, Christensen CK, Lederballe Pedersen O. Acute natriuretic effect of nifedipine in hypertensive patients and normotensive controls. A proximal tubular effect? Eur J Clin Pharmacol 1987;32:121-6.
27. Ruilope LM, Miranda B, Oliet A, Alcazar JM, Bigazza J, Rodicio JL. Persistence of the natriuretic effect of calcium-entry-blockers. J Cardiovasc Pharmacol 1988;12(suppl 4): S136-9.
28. Krusell LR, Jespersen LT, Schmnitz A, Thomsen K, Pedersen OL. Repetitive natriuresis and blood pressure long-term calcium-entry blockade with isradipine. Hypertension 1987;10:577-81.
29. Luft FC. Calcium-channels blocking drugs and renal sodium excretion. Am J Nephrol 1987;7(suppl 1):39-43.
30. Calò L, Cantaro S, Piccoli A, et al. Effect of nifedipine on urinary excretion of calcium and calcium-controlling hormones in essential hypercalciuria. Cardiovasc Drugs Ther 1990;4:983-6.
31. Boesgaard S, Hyldstrup L, Feldstedt M, and the Danish Study Group on Verapamil in Myocardial Infarction. Changes in calcium homeostasis and bone formation in patients recovering from acute myocardial infarction: effect of verapamil treatment. Eur J Clin Pharmacol 1991;41:521-3.
32. Lind L, Arvo A, Hvarfner A, Pollare T, Ljunghall S, Lithell H. Influences of different antihypertensive treatments of indices of systemic mineral metabolism. Am J Hypertens 1994; 7:302-7.
33. Soro S, Cocca A, Pasanisi F, et al. The effects of nicardiopine on sodium and calcium metabolism in hypertensive patients: a chronic study. J Clin Pharmacol 1990;30:133-7.
34. McCarron DA, Rankin LI, Bennett WM, et al. Urinary calcium excretion at extremes of sodium intake in normal man. Am J Nephrol 1981;1:84-90.
35. Oshima T, Matsuura H, Kido K. Intralymphocytic sodium and free calcium concentration in relation to salt sensitivity in patients with essential hypertension. Jpn Circ J 1987;51: 1184-90.
36. Oshima T, Matsuura H, Matsumoto K, Kido K. Role of cellular calcium in salt-sensitivity of patients with essential hypertension. Hypertension 1988;11:329-34.
37. Kusaka M, Atarashi K, Matsumoto K, et al. Plasma renin activity and norepinephrine as predictors for antihypertensive effects of nifedipine and captopril. Am J Hypertens 1991;4:735-9.
38. Dichtchekenian V, Gisiger S, Quental I, et al. Higher salt consumption, digoxin-like factor, and nifedipine response are associated with salt-sensitivity in essential hypertension. Am J Hypertens 1992;5:707-12.